This generous interpretation of the duties of the pharmaceutical companies and the State makes the Brazilian model for post-trial access unique when compared to the experience of other countries and thus should be followed with attention by future research in order to assess its consequences for ...
Indeed, this “sales with kickbacks” model is often used not only by small companies without competitive products but also by many large companies. From 2016 to 2019, more than half of the top 100 pharmaceutical companies in China provided kickbacks directly or indirectly [70]. Recently, un...
Aptar Pharma is a trusted partner to many pharmaceutical companies to bring drug delivery solutions to market quickly and efficiently.
Aptar Pharma is a trusted partner to many pharmaceutical companies to bring drug delivery solutions to market quickly and efficiently.
Medicilon has completed the R&D and filing of several topical preparation research projects for pharmaceutical companies and scientific research units. Highlights of Formulation Development Professional Platform for Insoluble CompoundsHot Melt Extrusion, Micronization, Solubilization Techniques, Comprehensive ...
since its inception in 1996. Mr. Peres serves on the board of directors of numerous Pitango portfolio companies. Mr. Peres is also the founder of Mofet Israel Technology Fund, one of Israel’s first venture capital funds, since its inception in 1992. Mr. Peres is chairman of the Peres Cen...
Lonza Launches Tailored Offering for Smart Capsules Companies Developing Oral Delivery Solutions for... View article 19 Sep 2024 Media Advisory Lonza Launches Innovaform™ Accelerator, the New Innovation and Formulation Center in Colmar (FR) View article Previous Next Our network Capsules & Hea...
In the same period, 23 major state-owned pharmaceutical companies had sales of $10 billion. A survey of 16 typical city hospitals, the usage of drugs increased by 32.23% in the first half of 2004 as compared with that of 2003. Around 36% of all China’s pharmaceutical enterprises are ...
Significant progress has been achieved in human health in the European Union in recent years. New medicines, vaccines, and treatments have been developed to tackle some of the leading causes of disease and life-threatening illnesses. It is clear that investment in research and development (R&D) ...
Keywords: corporate social responsibility;COVID-19;vaccines;global health;COVAX;pharmaceutical companies